A quiet month… that defines the rest of the year In Europe, August is associated with vacations, lighter agendas, and a slower pace.But in biotechnology and pharma, this apparent quiet is deceptive. While some take...
In Granada this June, I spoke to a familiar dilemma: how to keep momentum in biotech when funding is tight, valuations are down, and uncertainty is everywhere. I started with a simple idea: we are...
Innovation in biotechnology doesn’t happen in isolation. It emerges from the interaction of ideas, disciplines, and above all—people. That’s why, for LBBAL Alianza, joining Arahealth is a natural extension of our commitment to building the...
In today’s biotech landscape, what’s strategic is not only scientific. It is also tied to macroeconomic and geopolitical trends. And that’s exactly what we’ll explore on Wednesday, June 11, at the event “Global Strategies for Biotechnology”, held...
Our industry is undergoing a stress test. There are a multitude of destabilizing factors at play: As should be expected, biotech and pharma companies on both sides of the Atlantic are reevaluating their strategies. There...
The best way to determine how we can assist you best is to hold a live, non-confidential, complimentary 30 minute consultation. Please submit your inquiry and select a consultation time that works for you.
